SCHEMBL29782575

SCHEMBL29782575

Cc1[nH]c2cccc(Br)c2c1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.52
FEN1 P39748 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
ABL1 P00519 2/20 0.38
EGFR P00533 2/20 0.38
ABL2 P42684 2/20 0.38
CYP2A6 P11509 1/20 0.38
CCNB2 O95067 1/20 0.37
CCNE2 O96020 1/20 0.37
CDK1 P06493 1/20 0.37
CDK4 P11802 1/20 0.37
CCNB1 P14635 1/20 0.37
PRKACA P17612 1/20 0.37
PRKACG P22612 1/20 0.37
PRKACB P22694 1/20 0.37
CCND1 P24385 1/20 0.37
CCNE1 P24864 1/20 0.37
CDK2 P24941 1/20 0.37
CAMK2B Q13554 1/20 0.37
CAMK2G Q13555 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22609023 1.00 AHR (0.52) AHRFEN1SMN1; SMN2ABL1EGFR
Potassium SCHEMBL3627554 0.96 AHR (0.48) AHRFEN1SMN1; SMN2ABL1EGFR
SCHEMBL1921411 0.78 AHR (0.50) AHRSMN1; SMN2MAPTHTR2AHTR2C
SCHEMBL30439700 0.77 FEN1 (0.52) AHRFEN1CYP2A6CCNB2CCNE2
SCHEMBL6008314 0.77 FEN1 (0.52) AHRFEN1CYP2A6CCNB2CCNE2
SCHEMBL2057104 0.77 SMN1; SMN2 (0.43) AHRSMN1; SMN2ABL1EGFRABL2
SCHEMBL7490077 0.76 CYP2A6 (0.47) AHRFEN1CYP2A6CCNB2CCNE2
SCHEMBL3853007 0.76 TUBB4A (0.49) AHRFEN1SMN1; SMN2EGFRCCNB2
SCHEMBL6008267 0.75 ALDH1A1 (0.44) AHRFEN1CYP2A6CCNB2CCNE2
SCHEMBL21884850 0.75 AHR (0.47) AHRSMN1; SMN2ABL1EGFRABL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110511209-B Indole carboxamide compounds useful as kinase inhibitors 百时美施贵宝公司 2022-07-05 CN disclosed